Trials / Completed
CompletedNCT04222647
Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA
Prospective, Open-label, Monocenter, Trial to Investigate the Efficacy and Tolerability of WO533, a Lactic Acid Containing Vaginal Suppository, in a Panel of Post-menopausal Women Suffering From Vulvovaginal Atrophy (VVA)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Dr. August Wolff GmbH & Co. KG Arzneimittel · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to investigate the efficacy and tolerability of a lactic acid containing vaginal suppository with respect to the application in post-menopausal women with VVA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | WO533 | Intravaginal application |
Timeline
- Start date
- 2020-01-27
- Primary completion
- 2020-08-11
- Completion
- 2020-08-11
- First posted
- 2020-01-10
- Last updated
- 2021-12-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04222647. Inclusion in this directory is not an endorsement.